Double mastectomies halve death rate for BRCA1 or BRCA2 breast cancer patients

Woman with a genetic form of breast cancer who have double mastectomies are nearly 50 per cent less likely to die of the disease within 20 years of diagnosis than those who have only one breast removed, new research shows.

The findings, published Wednesday in the British Medical Journal, underscore the value of testing for the BRCA1 or BRCA2 genetic mutation and suggest that a double mastectomy may be an effective first-line treatment for those who carry it.

“This is the first study to ever highlight that having a bilateral mastectomy increases survival in these women,” explained lead author Kelly Metcalfe, an adjunct scientist at Women’s College Research Centre and professor at the University of Toronto.

Read the full, original story: Double mastectomies mean higher survival rates for some cancers

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend